Vir Biotechnology (NASDAQ:VIR) PT Raised to $27.00
Vir Biotechnology (NASDAQ:VIR – Get Rating) had its price target upped by Morgan Stanley from $25.00 to $27.00 in a report published on Tuesday, Benzinga reports. The firm currently has an equal weight rating on the stock. A number of other analysts have also recently issued reports on VIR. The Goldman Sachs Group raised Vir […]